OraSure to Participate in Upcoming Investor Conferences
OraSure Technologies, Inc. (NASDAQ: OSUR) announces participation in investor conferences. Live webcasts and replays available on the company's investor relations page.
11/13/2023 - 04:15 PM
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following investor conferences:
Stephens Annual Investment Conference on Wednesday, November 15, with a Q&A session scheduled for 2 p.m. ET Evercore ISI Annual HealthCONx Conference on Tuesday, November 28, with a Q&A session scheduled for 3 p.m. ET Live webcasts and replays of the sessions will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations . The webcasts will be archived on OraSure’s website and will be available for approximately 90 days.
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information through effortless tests, collection kits, and services. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services, and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com .
When is OraSure Technologies participating in investor conferences?
OraSure Technologies is scheduled to participate in the Stephens Annual Investment Conference on Wednesday, November 15, and the Evercore ISI Annual HealthCONx Conference on Tuesday, November 28.
Where can I access the webcasts and replays of the sessions?
The webcasts and replays will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. They will be archived on OraSure’s website for approximately 90 days.
Orasure Technologies Inc.
OSUR Rankings
#969 Ranked by Stock Gains
OSUR Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Bethlehem
About OSUR
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
